US 11124504
Kappa opioid receptor antagonists and products and methods related thereto
granted A61PA61P25/00A61P25/06
Quick answer
US patent 11124504 (Kappa opioid receptor antagonists and products and methods related thereto) held by BLACKTHORN THERAPEUTICS, INC. expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BLACKTHORN THERAPEUTICS, INC.
- Grant date
- Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 81
- CPC classes
- A61P, A61P25/00, A61P25/06